Why the Bod (ASX:BDA) share price is tracking 5% higher today

The Bod Australia Ltd (ASX: BDA) share price is up more than 5% today following the release of a positive trading update. Let's take a look.

| More on:
little green pharma share price represented by cannabis leaf character jumping cheerfully

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Bod Australia Ltd (ASX: BDA) share price is up more than 5% today following the release of a positive trading update.

At the time of writing, shares in the cannabis healthcare company are trading 5.3% higher at 49.5 cents.

What's driving the Bod share price higher?

The company has delivered record sales for the second-quarter of the 2021 financial year.

For the period ending December 31, total attributable sales came in at $3.3 million. This represents a 52% lift on the previous quarter, and 144% increase over the same time last year.

The strong performance was underpinned by a number of purchase orders from Bod's exclusive global partner, Health & Happiness. The latter recently launched CBD and hemp products across European markets such as the Netherlands, France, Italy, and the United Kingdom.

In addition, Bod revealed that an uptick in prescription volumes of its medicinal cannabis product, MediCabilis, contributed to the sound result.

In addition, the company says that both its cannabis medical division and CBD and Hemp consumer products are generating strong recurring revenue.

Bod further noted that sales growth is expected to continue in the current quarter and foreseeable future. This is backed by the company strategically entering new attractive markets while focusing on growth in Australian and United Kingdom medicinal cannabis sales.

Comments from the CEO

Bod CEO Jo Patterson, hailed the milestone, saying:

The progress achieved over the last quarter is a great result for Bod. The company has considerably broadened its international footprint, with new market entries into the Netherlands, France and Italy, as well as extended its product ranges in the UK. Further, we have increased sales of our medicinal cannabis products in Australia and are now benefitting from this growth.

Demand for our medicinal cannabis, and CBD and hemp products continues to escalate and we expect binding purchase orders to increase during the current period and the remainder of FY2021. Bod has also retained a strong cash balance, which will allow it to progress a number of initiatives including new market entries and product launches. We look forward to updating shareholders on progress over the coming months.

About the Bod share price

The Bod share price has gained 312% over its multi-year low of 12 cents reached in March last year, outperforming the All Ordinaries Index (ASX: XAO) in the same time frame.
Shares in the company hit an all-time high of 74 cents at the start of December.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Two workers at an oil rig discuss operations.
Broker Notes

Should you buy Santos, Beach Energy or Woodside shares? Here's Macquarie's top pick

Macquarie has released its new share price expectations for Santos, Beach Energy and Woodside shares.

Read more »

A green fully charged battery symbol surrounded by green charge lights representing the surging Vulcan share price today
Share Market News

Up 300% in 6 months! This soaring ASX lithium stock just took a major step to production

Marching forward.

Read more »

An old-fashioned panel of judges each holding a card with the number 10
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A young man pointing up looking amazed, indicating a surging share price movement for an ASX company
Share Market News

Macquarie says this top ASX tech stock could rise 15%

Let's see what the broker is saying about this stock.

Read more »

Excited couple celebrating success while looking at smartphone.
Healthcare Shares

Up 680% since July, here's why 2025 was a breakout year for this hot ASX stock

With consistent contract wins, FDA clearance, and backing from Pro Medicus, 4D Medical is showing that there is a commercial…

Read more »

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why Collins Foods, Monash IVF, Premier Investments, and Step One shares are tumbling today

These shares are ending the week in the red. But why?

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Share Gainers

4 ASX 200 stocks smashing the benchmark this week

Investors have been piling into these four ASX 200 stocks this week. Let’s see why.

Read more »